General form for registration of securities under the Securities Act of 1933

ACCOUNTS RECEIVABLE

v3.25.2
ACCOUNTS RECEIVABLE
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Receivables [Abstract]    
ACCOUNTS RECEIVABLE

NOTE 3 – ACCOUNTS RECEIVABLE

 

Accounts receivable were as follows at March 31, 2025 and December 31, 2024:

           
    March 31,
2025
    December 31,
2024
 
Accounts receivable   $ 215,060     $ 185,044  
Accounts receivable - related party    

1,760,625

     

294,434

 
Allowance for credit losses           (76,037 )
Accounts receivable, net   $ 1,975,685     $ 403,441  

 

The Company recorded bad debt expense (recovery) of $(76,307) and zero for the three months ended March 31, 2025 and 2024, respectively.

 

A summary of the activity related to our allowance for credit losses at March 31, 2025 and December 31, 2024 is summarized below. 

               
    March 31,
2025
    December 31,
2024
 
Allowance for credit losses, beginning balance   $ (76,037 )   $  
Allowance for credit losses provision           (76,037 )
Less recoveries     76,037        
Allowance for credit losses, ending balance   $     $ (76,037 )

  

NOTE 3 – ACCOUNTS RECEIVABLE

 

Accounts receivable were as follows at December 31, 2024 and 2023:

           
    December 31,
2024
    December 31,
2023
 
Accounts receivable   $ 479,478     $ 1,462,463  
Allowance for credit losses     (76,037 )      
Accounts Receivable, net   $ 403,441     $ 1,462,463  

 

The Company recorded bad debt expense in the amount of $76,037 and zero for the years ended December 31, 2024 and December 31, 2023, respectively.

 

A summary of the activity related to our allowance for credit losses during the year ended December 31, 2024 is summarized below. 

 Schedule of allowance for doubtful accounts      
    Amounts  
Allowance for doubtful accounts, beginning balance   $  
Allowance for doubtful accounts provision     (76,037 )
Less recoveries      
Allowance for doubtful accounts, ending balance   $ (76,037 )